summit trial tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Impact of Obesity Severity on

These gastrointestinal symptoms are typically most pronounced during dose escalation and tend to diminish over time as patients develop tolerance

Insurers typically require: BMI 30 (or 27 with comorbidities like diabetes, hypertension) Documentation of lifestyle interventions (diet, exercise) tried first Sometimes a letter of medical necessity from the prescriber Some plans impose quantity limits (e.g., initial 30-day supply only) to monitor adherence before approving refills

This makes it beneficial not just for weight control, but also for metabolic health overall

10.1038/nm.4068 37 Ben-ZionZ.KoremN.SpillerT

Neurosurgery 2008

The EVOKE and EVOKE Plus trials are examining oral semaglutide in individuals with early Alzheimer's disease, representing some of the largest prospective studies in this area